Intervention Review

Safety of topical corticosteroids in pregnancy

  1. Ching-Chi Chi1,2,*,
  2. Chia-Wen Lee3,
  3. Fenella Wojnarowska4,
  4. Gudula Kirtschig5

Editorial Group: Cochrane Skin Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 5 MAY 2009

DOI: 10.1002/14651858.CD007346.pub2


How to Cite

Chi CC, Lee CW, Wojnarowska F, Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007346. DOI: 10.1002/14651858.CD007346.pub2.

Author Information

  1. 1

    Chang Gung Memorial Hospital, Department of Dermatology and Centre for Evidence-Based Medicine, Chiayi, Taiwan

  2. 2

    Chang Gung University College of Medicine, Taoyuan, Taiwan

  3. 3

    Pfizer Limited, Department of Outcome Research and Evidence Based Medicine, Tadworth, Surrey, UK

  4. 4

    University of Oxford, Nuffield Department of Clinical Medicine, Oxford, UK

  5. 5

    VU University Medical Center Amsterdam, Department of Dermatology, Amsterdam, Netherlands

*Ching-Chi Chi, Department of Dermatology and Centre for Evidence-Based Medicine, Chang Gung Memorial Hospital, 6, Sec West, Chia-Pu Road, Puzih, Chiayi, 61363, Taiwan. chingchi@cgmh.org.tw. chingchichi@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nannie Bangsgaard, Christina Rørbye, Lone Skov, Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments, American Journal of Clinical Dermatology, 2015,

    CrossRef

  2. 2
    Gudula Kirtschig, Christof Schaefer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  3. 3
    Luciano Sagliocca, Salvatore De Masi, Luigina Ferrigno, Alfonso Mele, Giuseppe Traversa, A pragmatic strategy for the review of clinical evidence, Journal of Evaluation in Clinical Practice, 2013, 19, 4
  4. 4
    Jillian Wong Millsop, Misha M. Heller, Jenny E. Murase, Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach, Dermatologic Therapy, 2013, 26, 4
  5. 5
    Inbal Braunstein, Victoria Werth, Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy, Dermatologic Therapy, 2013, 26, 4
  6. 6
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  7. 7
    Ching-Chi Chi, Shu-Hui Wang, Gudula Kirtschig, Fenella Wojnarowska, Systematic review of the safety of topical corticosteroids in pregnancy, Journal of the American Academy of Dermatology, 2010, 62, 4, 694

    CrossRef

  8. 8
    Michael Bigby, Hywel C. Williams, Appraising Systematic Reviews and Meta-Analyses,
  9. 9
    Yi-Chieh Chen, Ching-Chi Chi, Fuan Chiang Chan, Yu-Wen Wen, Low molecular weight heparin for prevention of microvascular occlusion in digital replantation, The Cochrane Library,
  10. 10
    Finola Delamere, Liz Doney, Laura Prescott, Shirley Manknell, The Cochrane Skin Group,